| Chugai Pharmaceutical (CHGCY) |
JP |
$95.374B |
35.78 |
| Zoetis (ZTS) |
US |
$69.448B |
26.29 |
| Daiichi Sankyo, - (DSNKY) |
JP |
$48.414B |
24.63 |
| Takeda Pharmaceutical (TAK) |
JP |
$47.824B |
10.59 |
| Sandoz Group AG (SDZNY) |
CH |
$18.977B |
0.00 |
| Summit Therapeutics (SMMT) |
US |
$18.321B |
0.00 |
| Merck (MKKGY) |
DE |
$17.848B |
14.77 |
| Shionogi (SGIOY) |
JP |
$14.096B |
14.12 |
| United Therapeutics (UTHR) |
US |
$13.255B |
11.73 |
| Neurocrine Biosciences (NBIX) |
US |
$10.546B |
32.40 |
| IPSEN (IPSEY) |
FR |
$9.907B |
0.00 |
| Orion OYJ (ORINY) |
FI |
$9.027B |
24.41 |
| Corcept Therapeutics (CORT) |
US |
$7.580B |
57.65 |
| Madrigal Pharmaceuticals (MDGL) |
US |
$7.276B |
0.00 |
| Stevanato Group S.p.A (STVN) |
IT |
$6.281B |
39.88 |
| Ono Pharmaceutical (OPHLF) |
JP |
$5.988B |
12.26 |
| Hikma Pharmaceuticals Plc (HKMPF) |
GB |
$5.813B |
0.00 |
| Ionis Pharmaceuticals (IONS) |
US |
$5.047B |
0.00 |
| Grifols, S.A (GRFS) |
ES |
$4.827B |
0.00 |
| Soleno Therapeutics (SLNO) |
US |
$3.744B |
0.00 |
| Crinetics Pharmaceuticals (CRNX) |
US |
$3.138B |
0.00 |
| Catalyst Pharmaceuticals (CPRX) |
US |
$2.960B |
12.02 |
| AMNEAL PHARMACEUTICALS, INC (AMRX) |
US |
$2.399B |
14.89 |
| Hypermarcas (HYPMY) |
BR |
$2.350B |
15.46 |
| Recursion Pharmaceuticals (RXRX) |
US |
$2.211B |
0.00 |
| NewAmsterdam Pharma (NAMS) |
NL |
$2.200B |
0.00 |
| Centessa Pharmaceuticals (CNTA) |
GB |
$1.798B |
0.00 |
| Indivior (INDV) |
US |
$1.593B |
6.75 |
| Guardian Pharmacy Services (GRDN) |
US |
$1.568B |
0.00 |
| Evotec AG (EVO) |
DE |
$1.502B |
0.00 |
| ARS Pharmaceuticals (SPRY) |
US |
$1.391B |
177.00 |
| Dyne Therapeutics (DYN) |
US |
$1.362B |
0.00 |
| Ocular Therapeutix (OCUL) |
US |
$1.359B |
0.00 |
| Ardelyx (ARDX) |
US |
$1.304B |
0.00 |
| Aurinia Pharmaceuticals Inc (AUPH) |
CA |
$1.121B |
45.56 |
| Enliven Therapeutics (ELVN) |
US |
$0.974B |
0.00 |
| Harrow (HROW) |
US |
$0.917B |
0.00 |
| Collegium Pharmaceutical (COLL) |
US |
$0.869B |
4.62 |
| Avadel Pharmaceuticals (AVDL) |
IE |
$0.832B |
0.00 |
| Xencor (XNCR) |
US |
$0.773B |
0.00 |
| Cronos Group (CRON) |
CA |
$0.721B |
0.00 |
| AleAnna (ANNA) |
US |
$0.718B |
0.00 |
| Xeris Biopharma Holdings (XERS) |
US |
$0.701B |
0.00 |
| KalVista Pharmaceuticals (KALV) |
US |
$0.676B |
0.00 |
| Organogenesis (ORGO) |
US |
$0.629B |
0.00 |
| Akebia Therapeutics (AKBA) |
US |
$0.626B |
0.00 |
| Bioventus (BVS) |
US |
$0.595B |
15.45 |
| Savara (SVRA) |
US |
$0.563B |
0.00 |
| Relay Therapeutics (RLAY) |
US |
$0.561B |
0.00 |
| USANA Health Sciences (USNA) |
US |
$0.529B |
11.35 |
| Regulus Therapeutics (RGLS) |
US |
$0.520B |
0.00 |
| Theravance Biopharma (TBPH) |
KY |
$0.520B |
0.00 |
| Verve Therapeutics (VERV) |
US |
$0.490B |
0.00 |
| Tourmaline Bio (TRML) |
US |
$0.458B |
0.00 |
| Amylyx Pharmaceuticals (AMLX) |
US |
$0.458B |
0.00 |
| Elite Pharmaceuticals (ELTP) |
US |
$0.454B |
0.00 |
| Zevra Therapeutics (ZVRA) |
US |
$0.418B |
0.00 |
| Altimmune (ALT) |
US |
$0.398B |
0.00 |
| Siga Technologies (SIGA) |
US |
$0.388B |
6.62 |
| Oruka Therapeutics (ORKA) |
US |
$0.378B |
0.00 |
| CytoDyn (CYDY) |
US |
$0.368B |
0.00 |
| Heron Therapeutics (HRTX) |
US |
$0.358B |
0.00 |
| Rigel Pharmaceuticals (RIGL) |
US |
$0.334B |
19.92 |
| Aquestive Therapeutics (AQST) |
US |
$0.298B |
0.00 |
| ProKidney (PROK) |
US |
$0.250B |
0.00 |
| Avita Medical (RCEL) |
US |
$0.247B |
0.00 |
| Nature's Sunshine Products (NATR) |
US |
$0.227B |
26.70 |
| Wellgistics Health (WGRX) |
US |
$0.223B |
0.00 |
| OmniAb (OABI) |
US |
$0.216B |
0.00 |
| Esperion Therapeutics (ESPR) |
US |
$0.195B |
24.60 |
| MediWound (MDWD) |
IL |
$0.186B |
0.00 |
| Larimar Therapeutics (LRMR) |
US |
$0.183B |
0.00 |
| Korro Bio (KRRO) |
US |
$0.173B |
0.00 |
| Inhibikase Therapeutics (IKT) |
US |
$0.167B |
0.00 |
| Aldeyra Therapeutics (ALDX) |
US |
$0.162B |
0.00 |
| 4D Molecular Therapeutics (FDMT) |
US |
$0.159B |
0.00 |
| Journey Medical (DERM) |
US |
$0.159B |
0.00 |
| Lexeo Therapeutics (LXEO) |
US |
$0.156B |
0.00 |
| Nanobiotix S.A (NBTX) |
FR |
$0.156B |
0.00 |
| Procaps Group, S.A (PROCF) |
LU |
$0.156B |
0.00 |
| Aclaris Therapeutics (ACRS) |
US |
$0.149B |
0.00 |
| Ironwood Pharmaceuticals (IRWD) |
US |
$0.148B |
45.60 |
| Nektar Therapeutics (NKTR) |
US |
$0.145B |
0.00 |
| Profound Medical (PROF) |
CA |
$0.145B |
0.00 |
| Lyell Immunopharma (LYEL) |
US |
$0.139B |
0.00 |
| Protara Therapeutics (TARA) |
US |
$0.133B |
0.00 |
| Enanta Pharmaceuticals (ENTA) |
US |
$0.129B |
0.00 |
| Innate Pharma SA (IPHYF) |
FR |
$0.122B |
0.00 |
| Tonix Pharmaceuticals Holding (TNXP) |
US |
$0.116B |
0.00 |
| VAXART, INC (VXRT) |
US |
$0.098B |
0.00 |
| OptiNose (OPTN) |
US |
$0.095B |
0.00 |
| Cardiol Therapeutics (CRDL) |
CA |
$0.093B |
0.00 |
| Corbus Pharmaceuticals Holdings (CRBP) |
US |
$0.092B |
0.00 |
| Champions Oncology (CSBR) |
US |
$0.088B |
14.50 |
| Achieve Life Sciences (ACHV) |
CA |
$0.085B |
0.00 |
| Arch Biopartners (ACHFF) |
CA |
$0.083B |
0.00 |
| Galectin Therapeutics (GALT) |
US |
$0.082B |
0.00 |
| ESSA Pharma (EPIX) |
CA |
$0.079B |
0.00 |
| Cassava Sciences (SAVA) |
US |
$0.078B |
0.00 |
| Unicycive Therapeutics (UNCY) |
US |
$0.078B |
0.00 |
| Context Therapeutics (CNTX) |
US |
$0.077B |
0.00 |
| Telomir Pharmaceuticals (TELO) |
US |
$0.075B |
0.00 |
| Dominari Holdings (DOMH) |
US |
$0.075B |
0.00 |
| Nutriband (NTRB) |
US |
$0.070B |
0.00 |
| Pyxis Oncology (PYXS) |
US |
$0.068B |
0.00 |
| Cumberland Pharmaceuticals (CPIX) |
US |
$0.067B |
0.00 |
| Inotiv (NOTV) |
US |
$0.067B |
0.00 |
| Gain Therapeutics (GANX) |
US |
$0.064B |
0.00 |
| Assertio Holdings (ASRT) |
US |
$0.062B |
0.00 |
| Fractyl Health (GUTS) |
US |
$0.062B |
0.00 |
| Vivani Medical (VANI) |
US |
$0.062B |
0.00 |
| Allergy Therapeutics (AGYTF) |
GB |
$0.059B |
0.00 |
| Karyopharm Therapeutics (KPTI) |
US |
$0.058B |
0.00 |
| Metagenomi (MGX) |
US |
$0.056B |
0.00 |
| ElectroCore (ECOR) |
US |
$0.054B |
0.00 |
| Avalo Therapeutics (AVTX) |
US |
$0.054B |
0.00 |
| PMV Pharmaceuticals (PMVP) |
US |
$0.052B |
0.00 |
| Century Therapeutics (IPSC) |
US |
$0.048B |
0.00 |
| Mural Oncology (MURA) |
IE |
$0.045B |
0.00 |
| Verrica Pharmaceuticals (VRCA) |
US |
$0.043B |
0.00 |
| Acrivon Therapeutics (ACRV) |
US |
$0.042B |
0.00 |
| Reviva Pharmaceuticals Holdings (RVPH) |
US |
$0.041B |
0.00 |
| Prelude Therapeutics (PRLD) |
US |
$0.040B |
0.00 |
| Rafael Holdings (RFL) |
US |
$0.040B |
0.00 |
| Iterum Therapeutics (ITRM) |
IE |
$0.039B |
0.00 |
| SCYNEXIS (SCYX) |
US |
$0.038B |
0.00 |
| NRx Pharmaceuticals (NRXP) |
US |
$0.036B |
0.00 |
| Surrozen (SRZN) |
US |
$0.034B |
0.00 |
| FibroGen (FGEN) |
US |
$0.034B |
0.00 |
| PolyPid (PYPD) |
IL |
$0.029B |
0.00 |
| Tempest Therapeutics (TPST) |
US |
$0.025B |
0.00 |
| CASI Pharmaceuticals (CASI) |
CN |
$0.024B |
0.00 |
| Enlivex Therapeutics (ENLV) |
IL |
$0.022B |
0.00 |
| Jupiter Neurosciences (JUNS) |
US |
$0.021B |
0.00 |
| VYNE Therapeutics (VYNE) |
US |
$0.020B |
0.00 |
| Mannatech (MTEX) |
US |
$0.020B |
7.86 |
| Lipocine (LPCN) |
US |
$0.019B |
0.00 |
| Natural Alternatives (NAII) |
US |
$0.019B |
0.00 |
| DURECT (DRRX) |
US |
$0.018B |
0.00 |
| GlycoMimetics (GLYC) |
US |
$0.017B |
0.00 |
| TherapeuticsMD (TXMD) |
US |
$0.016B |
0.00 |
| Vivos Therapeutics (VVOS) |
US |
$0.016B |
0.00 |
| BioVie (BIVI) |
US |
$0.016B |
0.00 |
| MEI Pharma (MEIP) |
US |
$0.014B |
0.00 |
| ProPhase Labs (PRPH) |
US |
$0.014B |
0.00 |
| MARKER THERAPEUTICS, INC (MRKR) |
US |
$0.013B |
0.00 |
| TransCode Therapeutics (RNAZ) |
US |
$0.013B |
0.00 |
| Cosmos Health (COSM) |
US |
$0.013B |
0.00 |
| Scienture Holdings (SCNX) |
US |
$0.012B |
0.00 |
| Minerva Neurosciences (NERV) |
US |
$0.012B |
8.79 |
| Relmada Therapeutics (RLMD) |
US |
$0.012B |
0.00 |
| BioLineRx (BLRX) |
IL |
$0.011B |
0.00 |
| Plus Therapeutics (PSTV) |
US |
$0.011B |
0.00 |
| Ernexa Therapeutics (ERNA) |
US |
$0.010B |
0.00 |
| Kiora Pharmaceuticals (KPRX) |
US |
$0.010B |
3.16 |
| Biomerica (BMRA) |
US |
$0.009B |
0.00 |
| Addex Therapeutics (ADXN) |
CH |
$0.009B |
0.00 |
| Phio Pharmaceuticals (PHIO) |
US |
$0.009B |
0.00 |
| Talphera (TLPH) |
US |
$0.009B |
0.00 |
| Carisma Therapeutics (CARM) |
US |
$0.008B |
0.00 |
| Ainos (AIMD) |
US |
$0.008B |
0.00 |
| XTL Biopharmaceuticals (XTLB) |
IL |
$0.008B |
0.00 |
| Mangoceuticals (MGRX) |
US |
$0.008B |
0.00 |
| Nuvilex (PMCB) |
US |
$0.008B |
0.00 |
| Jaguar Animal Health (JAGX) |
US |
$0.008B |
0.00 |
| Indaptus Therapeutics (INDP) |
US |
$0.008B |
0.00 |
| Traws Pharma (TRAW) |
US |
$0.008B |
0.00 |
| Lyra Therapeutics (LYRA) |
US |
$0.007B |
0.00 |
| Citius Pharmaceuticals (CTXR) |
US |
$0.007B |
0.00 |
| Conduit Pharmaceuticals (CDT) |
US |
$0.006B |
0.00 |
| Sonoma Pharmaceuticals (SNOA) |
US |
$0.006B |
0.00 |
| NLS Pharmaceutics (NLSP) |
CH |
$0.005B |
0.00 |
| Klotho Neurosciences (KLTO) |
US |
$0.005B |
0.00 |
| Aptorum Group (APM) |
GB |
$0.005B |
0.00 |
| CERo Therapeutics Holdings (CERO) |
US |
$0.005B |
0.00 |
| Clearmind Medicine (CMND) |
CA |
$0.004B |
0.00 |
| Xenetic Biosciences (XBIO) |
US |
$0.004B |
0.00 |
| XORTX Therapeutics (XRTX) |
CA |
$0.004B |
0.00 |
| Quoin Pharmaceuticals (QNRX) |
US |
$0.004B |
0.00 |
| Redhill Biopharma (RDHL) |
IL |
$0.004B |
0.00 |
| InMed Pharmaceuticals (INM) |
CA |
$0.004B |
0.00 |
| Alaunos Therapeutics (TCRT) |
US |
$0.004B |
0.00 |
| 60 Degrees Pharmaceuticals (SXTP) |
US |
$0.004B |
0.00 |
| SciSparc (SPRC) |
IL |
$0.003B |
0.00 |
| Qualigen Therapeutics (QLGN) |
US |
$0.003B |
0.00 |
| Incannex Healthcare (IXHL) |
AU |
$0.002B |
0.00 |
| Galmed Pharmaceuticals (GLMD) |
IL |
$0.002B |
0.00 |
| TNF Pharmaceuticals (TNFA) |
US |
$0.002B |
0.00 |
| PainReform (PRFX) |
IL |
$0.002B |
0.00 |
| Shuttle Pharmaceuticals Holdings (SHPH) |
US |
$0.002B |
0.00 |
| China SXT Pharmaceuticals (SXTC) |
CN |
$0.002B |
0.00 |
| SHINECO (SISI) |
CN |
$0.002B |
0.00 |
| Salarius Pharmaceuticals (SLRX) |
US |
$0.001B |
0.00 |
| Heatwurx (PCSA) |
US |
$0.001B |
0.00 |
| Petros Pharmaceuticals (PTPI) |
US |
$0.001B |
0.00 |
| Universe Pharmaceuticals INC (UPC) |
CN |
$0.000B |
0.00 |
| Aditxt (ADTX) |
US |
$0.000B |
0.00 |
| 4D Pharma (LBPS) |
GB |
$0.000B |
0.00 |
| Patheon (PTHN) |
NL |
$0.000B |
0.00 |
| RVL Pharmaceuticals (RVLP) |
US |
$0.000B |
0.00 |
| Silence Therapeutics (SLN) |
GB |
$0.000B |
0.00 |
